RIFAMPIN-RESISTANT TUBERCULOSIS
Clinical trials for RIFAMPIN-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new RIFAMPIN-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for RIFAMPIN-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test strategy aims to cut TB treatment dropouts
Disease control Recruiting nowThis study tests whether regularly measuring linezolid levels in the blood can prevent dangerous side effects and keep people on their tuberculosis treatment. About 280 adults with rifampin-resistant TB will be randomly assigned to either standard care or dose adjustments based o…
Matched conditions: RIFAMPIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
DNA test could revolutionize treatment for Drug-Resistant TB
Diagnosis Recruiting nowThis study tests whether a DNA sequencing test can help doctors choose the right antibiotics for people with drug-resistant tuberculosis (TB). Researchers will collect samples from 2,500 participants in clinics and use targeted sequencing to identify which drugs the TB bacteria a…
Matched conditions: RIFAMPIN-RESISTANT TUBERCULOSIS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC